Melanie Kelly

Fondatore presso Panag Pharma, Inc.

Health Technology

Profilo

Melanie Kelly is the founder of TALLC Corp., Inc. and Panag Pharma, Inc. At TALLC Corp., Inc., she holds no specific title.
At Panag Pharma, Inc., she held the title of Chief Scientific Officer, but was no longer active in that role.

Posizioni attive di Melanie Kelly

Società	Posizione	Inizio
Panag Pharma, Inc. Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada.	Fondatore	-

Tutte le posizioni attive di Melanie Kelly

Precedenti posizioni note di Melanie Kelly

Società	Posizione	Fine
TALLC Corp., Inc. TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada.	Fondatore	-

Vedi nel dettaglio l'esperienza di Melanie Kelly

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Melanie Kelly

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Panag Pharma, Inc. Panag Pharma, Inc. Pharmaceuticals: MajorHealth Technology Panag Pharma, Inc. engages in the development of novel cannabinoid-based formulations for the treatment of pain and inflammation. Its product Topical A, provides a new approach to the treatment of chronic pain and inflammation. The company was founded by Mary Lynch, Melanie Kelly, Christian Lehmann, and Orlando Hung and is headquartered in Halifax, Canada.	Health Technology
TALLC Corp., Inc. TALLC Corp., Inc. Pharmaceuticals: MajorHealth Technology TALLC Corp, Inc. operates as a pre-clinical stage pharmaceutical company. It focuses on the development of TA-A001, a novel endocannabinoid CB2 receptor activator with potent anti-inflammatory analgesic properties. The company was founded by Damon Smith, Melanie Kelly and Guy Chamberland and is headquartered in Laval, Canada.	Health Technology